So you are now a Surgeon
In this presentation, a functional neurosurgeon emphasizes the growing role of interventional pain physicians in performing minimally invasive surgical procedures, such as spinal cord stimulation and interspinous fusion. He urges practitioners to adopt a surgical mindset, stressing the importance of infection control, patient screening, wound care, and postoperative monitoring. Drawing from experience and data, he notes that prior infections—not obesity or diabetes—are key predictors of post-op infections. He highlights the shift in pain management from conservative therapies to procedural interventions and calls for increased training, surgical standards, and collaborative care to support safe and effective patient outcomes.
Watch Now
NEWEST VIDEO
Watch Now
NEWEST VIDEO
The Affective Side of Pain Targeting the Medial Pathway
Dr. Pankaj Mehta discusses the evolution of neuromodulation in pain management, emphasizing the importance of targeting the medial pain pathway, which influences the emotional and affective component of pain—suffering—not just the sensory pain intensity (lateral pathway). He highlights the limitations of relying solely on VAS scores and advocates for a more holistic approach using psychometric assessments and advanced therapies like BurstDR stimulation. By activating the medial pathway, physicians can better treat chronic pain patients who present with complex, longstanding suffering. Real-world and clinical evidence support BurstDR's ability to address both pain and suffering, improving outcomes in diverse patient populations.
Watch Now
Watch Now
NEWEST VIDEOS
This presentation explores the evolving landscape of neuromodulation, highlighting its expanding role beyond pain management to treat neurological disorders like epilepsy, depression, Parkinson’s disease, and overactive bladder. Emphasizing mechanisms such as synaptic modulation and neurotransmitter regulation, the speaker outlines how new technologies, improved waveforms, and advanced imaging have enabled less invasive and more targeted therapies. Real-world examples and clinical insights illustrate neuromodulation’s potential in both peripheral and central nervous systems. The speaker calls for continued research to validate broader applications and envisions neuromodulation as a transformative tool for a range of complex and chronic conditions.
Watch Now
Watch Video
Novel Targets of Neuromodulation, Expading your Practice
NEWEST VIDEO
Saving our Space
This powerful talk addresses the existential crisis facing neuromodulation, not from lack of clinical efficacy, but from public perception shaped by media attacks, poor studies, fraud, and unethical practices. While evidence-based medicine has advanced the field, it has failed to protect access, reimbursement, or respect. The speaker argues that to survive, the field must shift focus from only generating data to actively restoring public trust. That includes independent registries, ethical education, stronger patient advocacy, stricter training and certification, and transparent collaboration among clinicians, societies, and industry. Ultimately, the field’s future depends not just on outcomes—but on how it is perceived.
Watch Now
Watch Now
Watch Now
NEWEST VIDEO
Watch Now
Creating the Singularity where is neuromodulation taking us
growth becomes exponential and irreversible. He challenges the idea of hardware unification across companies and instead reframes singularity as a coming wave of revolutionary innovation. Highlighting breakthroughs in neurorestoration, brain-computer interfaces, optogenetics, and AI-driven performance enhancement, he envisions a future where neuromodulation reshapes mobility, cognition, and memory. From paralyzed patients walking again to implantable memory-enhancing technologies, Dr. Deer outlines how these advancements could transform pain management, disability care, and human potential—while cautioning about ethical implications and the “tribal” limitations of device brand loyalty.
Watch Now
In this presentation, a functional neurosurgeon emphasizes the growing role of interventional pain physicians in performing minimally invasive surgical procedures, such as spinal cord stimulation and interspinous fusion. He urges practitioners to adopt a surgical mindset, stressing the importance of infection control, patient screening, wound care, and postoperative monitoring. Drawing from experience and data, he notes that prior infections—not obesity or diabetes—are key predictors of post-op infections. He highlights the shift in pain management from conservative therapies to procedural interventions and calls for increased training, surgical standards, and collaborative care to support safe and effective patient outcomes.
So you are now a Surgeon
Watch Now
Dr. Pankaj Mehta discusses the evolution of neuromodulation in pain management, emphasizing the importance of targeting the medial pain pathway, which influences the emotional and affective component of pain—suffering—not just the sensory pain intensity (lateral pathway). He highlights the limitations of relying solely on VAS scores and advocates for a more holistic approach using psychometric assessments and advanced therapies like BurstDR stimulation. By activating the medial pathway, physicians can better treat chronic pain patients who present with complex, longstanding suffering. Real-world and clinical evidence support BurstDR's ability to address both pain and suffering, improving outcomes in diverse patient populations. The Affective Side of Pain Targeting the Medial Pathway
Watch Now
Novel Targets of Neuromodulation, Expading your Practice
This presentation explores the evolving landscape of neuromodulation, highlighting its expanding role beyond pain management to treat neurological disorders like epilepsy, depression, Parkinson’s disease, and overactive bladder. Emphasizing mechanisms such as synaptic modulation and neurotransmitter regulation, the speaker outlines how new technologies, improved waveforms, and advanced imaging have enabled less invasive and more targeted therapies. Real-world examples and clinical insights illustrate neuromodulation’s potential in both peripheral and central nervous systems. The speaker calls for continued research to validate broader applications and envisions neuromodulation as a transformative tool for a range of complex and chronic conditions.
Watch Now
This powerful talk addresses the existential crisis facing neuromodulation, not from lack of clinical efficacy, but from public perception shaped by media attacks, poor studies, fraud, and unethical practices. While evidence-based medicine has advanced the field, it has failed to protect access, reimbursement, or respect. The speaker argues that to survive, the field must shift focus from only generating data to actively restoring public trust. That includes independent registries, ethical education, stronger patient advocacy, stricter training and certification, and transparent collaboration among clinicians, societies, and industry. Ultimately, the field’s future depends not just on outcomes—but on how it is perceived. Saving our Space
Watch Now
growth becomes exponential and irreversible. He challenges the idea of hardware unification across companies and instead reframes singularity as a coming wave of revolutionary innovation. Highlighting breakthroughs in neurorestoration, brain-computer interfaces, optogenetics, and AI-driven performance enhancement, he envisions a future where neuromodulation reshapes mobility, cognition, and memory. From paralyzed patients walking again to implantable memory-enhancing technologies, Dr. Deer outlines how these advancements could transform pain management, disability care, and human potential—while cautioning about ethical implications and the “tribal” limitations of device brand loyalty.
Creating the Singularity where is neuromodulation taking us
